Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Toward personalized medicine in schizophrenia: Genetics and epigenetics of antipsychotic treatment
Amanda Lisoway, Cheng C. Chen, Clement C. Zai, et al.
Schizophrenia Research (2021) Vol. 232, pp. 112-124
Closed Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Neuroinflammation and Schizophrenia: New Therapeutic Strategies through Psychobiotics, Nanotechnology, and Artificial Intelligence (AI)
Freiser Eceomo Cruz Mosquera, Maria Camila Guevara-Montoya, Valentina Serna-Ramirez, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 4, pp. 391-391
Open Access | Times Cited: 16
Optimisation of pharmacotherapy in psychiatry through therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests: Focus on antipsychotics
X.M. Hart, Gerhard Gründer, Nicolas Ansermot, et al.
The World Journal of Biological Psychiatry (2024) Vol. 25, Iss. 9, pp. 451-536
Closed Access | Times Cited: 9
Epidrugs in the Therapy of Central Nervous System Disorders: A Way to Drive on?
Marina G. Gladkova, Este Leidmaa, Elmira Anderzhanova
Cells (2023) Vol. 12, Iss. 11, pp. 1464-1464
Open Access | Times Cited: 17
Treatment of antipsychotic-induced hyperprolactinemia: an umbrella review of systematic reviews and meta-analyses
Qitong Jiang, Li Tian, Lei Zhao, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 5
The Progress and Pitfalls of Pharmacogenetics-Based Precision Medicine in Schizophrenia Spectrum Disorders: A Systematic Review and Meta-Analysis
Yuxin Teng, Amrit Sandhu, Edith J. Liemburg, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 3, pp. 471-471
Open Access | Times Cited: 10
Applied pharmacogenetics to predict response to treatment of first psychotic episode: study protocol
Sergi Mas, Laura Julià, Manuel J. Cuesta, et al.
Frontiers in Psychiatry (2025) Vol. 15
Open Access
Psychogenetic Features of Heredity and Pathology
Liana Spytska
The Journal of Nervous and Mental Disease (2025)
Closed Access
Identification of key genes and pathways in schizophrenia: a bioinformatics analysis based on GWAS and GEO
Alireza Shokrgozar, Maryam Rahimi, Shahrzad Shoraka
Frontiers in Psychiatry (2025) Vol. 16
Open Access
Genetic Predisposition of TLR 1 and TLR 6 Polymorphisms to Schizophrenia Onset and Prediction of Treatment Response
Youssef Aflouk, Amira Kenz, Hana Saoud, et al.
Biochemical Genetics (2025)
Closed Access
Treatment-Resistant Schizophrenia, Clozapine Resistance, Genetic Associations, and Implications for Precision Psychiatry: A Scoping Review
Jiangbo Ying, Qian Hui Chew, Roger S. McIntyre, et al.
Genes (2023) Vol. 14, Iss. 3, pp. 689-689
Open Access | Times Cited: 9
Changes in BDNF methylation patterns after cognitive remediation therapy in schizophrenia: A randomized and controlled trial
Rafael Penadés, Carmen Almodóvar-Payá, Clemente García‐Rizo, et al.
Journal of Psychiatric Research (2024) Vol. 173, pp. 166-174
Closed Access | Times Cited: 3
Zebrafish Is a Powerful Tool for Precision Medicine Approaches to Neurological Disorders
Katarzyna Ochenkowska, Aveeva Herold, Éric Samarut
Frontiers in Molecular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 14
Pharmacogenetics and Schizophrenia—Can Genomics Improve the Treatment with Second-Generation Antipsychotics?
Olga Płaza, Piotr Gałecki, Agata Orzechowska, et al.
Biomedicines (2022) Vol. 10, Iss. 12, pp. 3165-3165
Open Access | Times Cited: 11
Antipsychotics in the Management of Disruptive Behavior Disorders in Children and Adolescents: An Update and Critical Review
Ravi Philip Rajkumar
Biomedicines (2022) Vol. 10, Iss. 11, pp. 2818-2818
Open Access | Times Cited: 10
Pharmacogenetics of Antipsychotic Treatment in Schizophrenia
Samar S. M. Elsheikh, Daniel J. Müller, Jennie G. Pouget
Methods in molecular biology (2022), pp. 389-425
Closed Access | Times Cited: 8
Virtual histology of morphometric similarity network after risperidone monotherapy and imaging-epigenetic biomarkers for treatment response in first-episode schizophrenia
Xiaofen Zong, Jiangbo Zhang, Lei Li, et al.
Asian Journal of Psychiatry (2022) Vol. 80, pp. 103406-103406
Open Access | Times Cited: 8
The Effect of Memantine Versus Folic Acid on Cognitive Impairment in Patients with Schizophrenia: A Randomized Clinical Trial
Seyed Ahmad Hosseini, Zahra Sepehrmanesh, Hamidreza Gilasi, et al.
Iranian Journal of Psychiatry (2023)
Open Access | Times Cited: 4
Pharmacogenetics of Long-Term Outcomes of Schizophrenia Spectrum Disorders: The Functional Role of CYP2D6 and CYP2C19
Amrit Sandhu, Elnaz Naderi, Morenika Wijninga, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 9, pp. 1354-1354
Open Access | Times Cited: 4
Distinctive Patterns of 5-Methylcytosine and 5-Hydroxymethylcytosine in Schizophrenia
Jiaxiang Xie, Yang Wang, Changcheng Ye, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 1, pp. 636-636
Open Access | Times Cited: 1
Investigating bilirubin concentrations in schizophrenia: A systematic review and meta-analysis
Donatella Coradduzza, Biagio Di Lorenzo, Stefania Sedda, et al.
Schizophrenia Research (2024) Vol. 271, pp. 228-236
Open Access | Times Cited: 1
Total Barley Maiya Alkaloids Prevent Increased Prolactin Levels Caused by Antipsychotic Drugs and Reduce Dopamine Receptor D2 via Epigenetic Mechanisms
Yu-Ling Cao, Li -Zhu, Hong Zhang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 4
Epigenome-Wide Studies of Antipsychotics: A Systematic Review and Pathway Meta-Analysis
Thomas Rowbal, Megan Kajy, Kyle J. Burghardt
Epigenomics (2023) Vol. 15, Iss. 20, pp. 1085-1094
Open Access | Times Cited: 2
Genomic stratification of clozapine prescription patterns using schizophrenia polygenic scores
Djenifer B. Kappel, Sophie E. Legge, Leon Hubbard, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 3
Factors Influencing Adherence to Antipsychotic Medications in Women with Delusional Disorder: A Narrative Review
Alexandre González-Rodríguez, José Antonio Monreal, Mary V. Seeman
Current Pharmaceutical Design (2022) Vol. 28, Iss. 15, pp. 1282-1293
Closed Access | Times Cited: 3
Metabolic, genetic, and pharmacokinetic parameters for the prediction of olanzapine efficacy
Ling Cong, Zirui Wan, Pengfei Li, et al.
European Journal of Pharmaceutical Sciences (2022) Vol. 177, pp. 106277-106277
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top